← Ticker index
ITCI
Ticker
ITCI
Congressional Trades
12
by 2 members
Ticker disclosure brief
Congressional disclosure records for ITCI
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Josh Gottheimer
SELL · 2025-04-03
Largest range
$1K – $15K
Josh Gottheimer
Longest observed gap
41d
Josh Gottheimer
Highest 30d vs SPY
69.4%
Josh Gottheimer
Purchase rows
0
0%
Sale rows
12
100%
Disclosed midpoint
$96K
range estimate
Unique Traders
2
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats12 · 100%
Republicans0 · 0%
Lobbying filings
all →- 2026-01-16$50KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health. H.R. 5376, Impacts and Outcomes for Health Career Training Act.
- 2025-10-16$50KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health. H.R. 5376, Impacts and Outcomes for Health Career Training Act.
- 2025-10-10$0INTRA-CELLULAR THERAPIES INC.
- 2025-07-21$10KINTRA-CELLULAR THERAPIES INC.H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act.
- 2025-07-21$10KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.
- 2025-04-21$70KINTRA-CELLULAR THERAPIES INC.H.R. 1492 - EPIC Act: Provisions regarding harmonizing small and large molecule period in the Inflation Reduction Act. H.R. 1990 - American Innovation and R&D Competitiveness Act: Provisions regarding Section 174 research and development tax credit amortization.
- 2025-04-21$50KINTRA-CELLULAR THERAPIES INC.Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.
Loading trade analytics…
All Disclosed Trades
Page 1 · 12 of 12 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-04-03 | DJosh Gottheimer | SELL | $1K – $15K | 41d | receipt → |
| 2025-04-03 | DJosh Gottheimer | SELL | $1K – $15K | 41d | receipt → |
| 2025-04-03 | DGilbert Cisneros | SELL | $1K – $15K | 33d | receipt → |
| 2025-04-03 | DGilbert Cisneros | SELL | $1K – $15K | 33d | receipt → |
| 2025-03-17 | DJosh Gottheimer | SELL | $1K – $15K | 24d | receipt → |
| 2025-03-17 | DJosh Gottheimer | SELL | $1K – $15K | 24d | receipt → |
| 2025-03-24 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-03-24 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-01-24 | DJosh Gottheimer | SELL | $1K – $15K | 17d | receipt → |
| 2025-01-24 | DJosh Gottheimer | SELL | $1K – $15K | 17d | receipt → |
| 2024-06-21 | DJosh Gottheimer | SELL | $1K – $15K | 18d | receipt → |
| 2024-06-21 | DJosh Gottheimer | SELL | $1K – $15K | 18d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.